National Comprehensive Cancer Network



About NCCN

Prostate Cancer Panel - Disclosures as of 12/3/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Andrew J. Armstrong, MD, ScM

None

Amgen Inc.;
Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Medivation

None

None

5/15/2013

Robert R. Bahnson, MD

None

None

None

None

11/12/2012

Barry Boston, MD

None

Bayer HealthCare;
Onyx Pharmaceuticals, Inc.;
Pfizer Inc.;
sanofi-aventis U.S.

None

None

10/19/2011

J. Erik Busby, MD

None

Centocor, Inc.

None

None

11/1/2011

Anthony Victor D'Amico, MD, PhD

None

None

None

None

10/8/2012

James A. Eastham, MD

None

None

None

None

10/8/2012

Charles A. Enke, MD

None

None

None

None

11/1/2011

Thomas A. Farrington

None

None

None

None

8/6/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Celestia S. Higano, MD, FACP

None

None

None

None

12/31/2012

Maria Ho, PhD

None

None

None

None

8/3/2012

Eric Mark Horwitz, MD

None

None

None

None

5/22/2012

Philip W. Kantoff, MD

None

Amgen Inc.;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
BIND Biosciences, Inc.;
Cougar Biotechnology, Inc.;
Forest Pharmaceuticals, Inc.;
Gerson Lehrman Group, Inc;
Guidepoint Global;
Tokia

None

None

4/9/2012

Mark H. Kawachi, MD

None

None

None

None

5/8/2012

Michael Kuettel, MD, MBA, PhD

None

None

None

None

10/9/2012

Richard J. Lee, MD, PhD

None

None

None

None

8/7/2012

Gary R. MacVicar, MD

None

Centocor, Inc.;
Novartis Pharmaceuticals Corporation;
sanofi-aventis U.S.

None

None

1/28/2013

Arnold W. Malcolm, MD, FACR

None

None

None

None

4/24/2013

Joan S. McClure, MS

None

None

None

None

7/23/2012

David Miller, MD, MPH

None

None

None

None

10/10/2012

James L. Mohler, MD

Roswell Park Cancer Institute

None

None

Androbiosys, Inc.

10/22/2012

Elizabeth R. Plimack, MD, MS

None

Johnson & Johnson;
Pfizer Inc.

None

None

10/17/2012

Julio M. Pow-Sang, MD

None

None

None

None

3/29/2013

Mack Roach III, MD

None

CareCore National LCC;
Molecular Insight, TROFEX

None

None

10/18/2011

Eric Rohren, MD, PhD

None

None

None

None

5/17/2013

Stan Rosenfeld

None

None

None

None

10/22/2012

Dorothy Shead, MS

None

None

None

None

8/3/2012

Sandy Srinivas, MD

None

Genentech, Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

11/5/2012

Seth A. Strope, MD, MPH

None

None

None

None

10/9/2012

Jonathan Tward, MD, PhD

None

None

None

None

8/3/2012

Przemyslaw Twardowski, MD

None

AstraZeneca Pharmaceuticals LP

None

None

10/18/2011

Patrick C. Walsh, MD

None

None

None

None

7/31/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved